NCT02102646View on ClinicalTrials.gov

MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Prostate CancerMetabolic SyndromeHypogonadismFatty Liver
Interventions
DRUG

Triptorelin

Androgen deprivation therapy by Pamorelin 22,5mg/24 weeks administered intramuscularly.

PROCEDURE

Orchiectomy

Androgen deprivation therapy by bilateral subcapsular orchiectomy

Trial Locations (1)

2730

Herlev Hospital, Herlev

All Listed Sponsors
lead

Herlev Hospital

OTHER

NCT02102646 - MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism | Biotech Hunter | Biotech Hunter